Somatostatin Analogues Use in Other than Endocrine Tumor Indications

[1]  M. Vranic,et al.  Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats , 2013, Diabetes.

[2]  A. Schally,et al.  Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124] , 2013, Anti-cancer drugs.

[3]  Chengwei Tang,et al.  Prevention of Severe Acute Pancreatitis With Octreotide in Obese Patients: A Prospective Multi-Center Randomized Controlled Trial , 2012, Pancreas.

[4]  Y. Bentur,et al.  Octreotide for the treatment of sulfonylurea poisoning , 2012, Clinical toxicology.

[5]  A. Maubon,et al.  Lanreotide Autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: a phase III double blind, randomized, placebo-controlled trial. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  D. Kokona,et al.  Pasireotide (SOM230) protects the retina in animal models of ischemia induced retinopathies. , 2012, Experimental eye research.

[7]  D. Goulis,et al.  Abstract. Background: Antisurvival Factor Therapy for Prostate Dexamethasone plus Somatostatin-analog Manipulation as Bone Metastasis Microenvironment-targeting Therapy for the Treatment of Castration-resistant Prostate Cancer: a Meta-analysis of Uncontrolled Studies , 2022 .

[8]  V. Weinberg,et al.  Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II study. , 2012, Urologic oncology.

[9]  M. Mrkobrada,et al.  Meta‐analysis: vasoactive medications for the management of acute variceal bleeds , 2012, Alimentary pharmacology & therapeutics.

[10]  J. Kountouras,et al.  Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial , 2012, Endoscopy.

[11]  T. Whelan,et al.  Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Shi-yong Li,et al.  Somatostatin analogues in advanced hepatocellular carcinoma: An updated systematic review and meta-analysis of randomized controlled trials , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[13]  H. Schaible,et al.  Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis. , 2011, Arthritis and rheumatism.

[14]  D. Modan-Moses,et al.  Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel). , 2011, The Journal of clinical endocrinology and metabolism.

[15]  T. Cascino,et al.  Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma. , 2011, Neuro-oncology.

[16]  C. Schulz,et al.  Treatment of unresectable skull base meningiomas with somatostatin analogs. , 2011, Neurosurgical focus.

[17]  T. Fukui,et al.  Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis , 2010, Journal of Gastroenterology.

[18]  K. Gurusamy,et al.  Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[19]  M. Peeters,et al.  Diarrhea and the rationale to use Sandostatin. , 2010, Acta gastro-enterologica Belgica.

[20]  P. Rehak,et al.  Effect of somatostatin analogue octreotide on pain relief after major abdominal surgery , 2009, European journal of pain.

[21]  A. Schally,et al.  Inhibition of human non-small cell lung cancers with a targeted cytotoxic somatostatin analog, AN-162 , 2009, Peptides.

[22]  L. Leibovici,et al.  Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis. , 2009, The Journal of clinical endocrinology and metabolism.

[23]  D. Ma,et al.  Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice. , 2008, European journal of pharmacology.

[24]  A. Kiss,et al.  Somatostatin and gabexate for post‐endoscopic retrograde cholangiopancreatography pancreatitis prevention: Meta‐analysis of randomized placebo‐controlled trials , 2007, Journal of gastroenterology and hepatology.

[25]  E. Soto-Pedre,et al.  Sandostatin LAR for cystoid diabetic macular edema: a 1-year experience. , 2004, Diabetes research and clinical practice.

[26]  G. D’Amico,et al.  Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. , 2003, Gastroenterology.

[27]  M. Grant,et al.  Somatostatin analogues as drug therapies for retinopathies. , 2002, Drugs of today.

[28]  I. Shrier,et al.  Systematic review: the use of somatostatin or octreotide in refractory diarrhoea , 2001, Alimentary pharmacology & therapeutics.

[29]  M. Yaron,et al.  A pilot study of a long acting somatostatin analogue for the treatment of refractory rheumatoid arthritis. , 2001, Annals of the rheumatic diseases.

[30]  S. H. Wilson,et al.  The therapeutic problem of proliferative diabetic retinopathy: targeting somatostatin receptors. , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[31]  A. Bellastella,et al.  Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy. , 2000, Journal of molecular endocrinology.

[32]  S. Lamberts,et al.  Imaging and medical management of clinically nonfunctioning pituitary tumors , 1995 .